Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Did you know how medwireNews writes our articles?

Filter

Date Title Topic
24 May 2017 Beta Blocker Use Linked To Advanced HER2-Negative Breast Cancer PFS Breast Cancer
23 May 2017 ARTemis Findings Confirm Computational Pathology Lymphocyte Density Linked To pCR Breast Cancer, Early Stage - Pathology/Molecular Biology
22 May 2017 Urinary RNA Test Points To Aggressive Prostate Cancer Prostate Cancer - Translational Research
19 May 2017 Final Trastuzumab Emtansine Findings Confirm OS Benefit In Advanced HER2-Positive Breast Cancer Anti-Cancer Agents & Biologic Therapy - Breast Cancer, Metastatic
18 May 2017 Elderly Stage III NSCLC Patients Experience Less Benefit, Greater Toxicity From Chemoradiation Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Locally Advanced - Surgery and/or Radiotherapy of Cancer
17 May 2017 Neoadjuvant Epirubicin Plus Ifosfamide Beats Histotype-Tailored Regimens For High-Risk Sarcoma DFS Anti-Cancer Agents & Biologic Therapy - Soft Tissue Sarcomas
16 May 2017 Subcutaneous Rituximab Feasible For Follicular Lymphoma Anti-Cancer Agents & Biologic Therapy - Lymphomas
15 May 2017 J-ALEX Results Point to Alectinib For First-Line ALK-Positive NSCLC Treatment Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Metastatic - Personalised Medicine
12 May 2017 First-Line Dabrafenib Plus Trametinib Extends Survival For BRAF V600-Mutated Metastatic Melanoma Anti-Cancer Agents & Biologic Therapy - Melanoma and other Skin Tumours - Personalised Medicine
11 May 2017 CPI-613 Plus Modified FOLFIRINOX ‘Well Tolerated’ For Metastatic Pancreatic Cancer Drug Development - Pancreatic Cancer
10 May 2017 Negative SELECT-1 Results For Previously Treated KRAS-Mutated Advanced NSCLC Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Metastatic
09 May 2017 ‘Substantial’ Brigatinib Responses Reported For ALK-Rearranged NSCLC With Crizotinib Resistance Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Metastatic - Personalised Medicine
08 May 2017 tAnGo At 10 Years Shows Adding Gemcitabine Does Not Boost Early Breast Cancer Survival Anti-Cancer Agents & Biologic Therapy - Breast Cancer, Early Stage
05 May 2017 ROMANA 3 Adds Extended Use Anamorelin Evidence For NSCLC-Related Cachexia Non-Small-Cell Lung Cancer, Metastatic - Palliative Care
04 May 2017 ctDNA Monitoring May Predict Immune Checkpoint Blocker Therapy Response Cancer Immunology and Immunotherapy - Translational Research